Prevent Inability To Control Urination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

417 participants

Study Classification

INTERVENTIONAL

Study Start Date

2000-09-30

Study Completion Date

2006-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the capacity of self-efficacy to predict maintaining a behavior change at four years post urinary control intervention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Promoting Self Care to Prevent Urinary Incontinence (UI): A Four-Year Follow-up

NCT00506766

Urinary Incontinence Bladder Control

COMPLETED PHASE3

Translating Unique Learning for Incontinence Prevention

NCT01599715

Urinary Incontinence

COMPLETED PHASE2

Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women

NCT00763984

Urinary Incontinence

COMPLETED PHASE3

Pelvic Floor Muscle Training on the Quality of Life in Women With Urinary Incontinence

NCT03514147

Urinary Incontinence Quality of Life

COMPLETED NA

The Urinary Incontinence Treatment Study

NCT03057834

Urinary Incontinence Sarcopenia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a study that will monitor and compare attitudes and strategies that women use to maintain behavior changes that prevent urination problems. Women will complete questionnaires, do muscle strength exercises, and bladder training at 3 months, one year, and 4 years post intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 Bladder Health Class

A two-hour bladder health class presented by two experts in urinary incontinence and followed by an individual follow-up teaching session with an incontinence nurse specialist.

Group Type OTHER

Bladder Health Class

Intervention Type BEHAVIORAL

A two-hour bladder health class presented by two experts in urinary incontinence and followed by an individual follow-up teaching session with an incontinence nurse specialist.

2 Control Group

Participants randomized to this arm did not receive any interventions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bladder Health Class

A two-hour bladder health class presented by two experts in urinary incontinence and followed by an individual follow-up teaching session with an incontinence nurse specialist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

1. Female 55 through 80 years old
2. Post-menopausal-no menstrual cycle for the past 12 months except for women who are on hormone replacement therapy.
3. Continent of urine (using the MESA definition of continence) defined as:

1. No previous incontinence episode except during pregnancy and/or postpartum period.
2. Urine loss less than 6 days during the last 365 days
3. No previous or present incontinence treatment with pharmacological agents, behavioral programs or surgical therapy.
4. No history of bladder cancer, stroke, multiple sclerosis, parkinsonism, epilepsy, spinal cord tumor or trauma.
5. No reported difficulty with activities of daily living, i.e. walking about the house, dressing, getting in/out of bed, getting to/using the toilet, bathing/showering, or eating.

Additional criteria are applied at a physical examination:

1. Mini Mental Status of at least 24
2. Negative for objective urine loss during coughing.

Minimum Eligible Age

55 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No